Entrevista con HLTH: La respuesta ante la COVID-19 de BioReference

Mientras el mundo entero está sintiendo los efectos del coronavirus (COVID-19), estamos agradecidos con la comunidad de la atención médica, en especial, con las personas que están en la primera línea de atención. On May 15, Dr. Jon Cohen, BioReference’s Executive Chairman spoke with HLTH, a large-scale forum for collaboration across senior leaders from established payers, providers, employers, pharma, startups, and investors, as well as representatives from government, health associations, media, about BioReference’s response to the COVID-19 pandemic.

What Topics Did Dr. Cohen Cover with HLTH?

  • Complexities and accuracy of serology (antibody) testing for COVID-19
  • Overall COVID-19 testing strategy in the United States
  • How BioReference is supporting employer COVID-19 screening programs, which will aid in return-to-work policies

About BioReference’s COVID-19 Response

En BioReference, nuestra prioridad sigue siendo la salud y la seguridad de nuestros empleados, de los proveedores de atención médica, los pacientes y las comunidades que atendemos; y estamos haciendo lo posible para brindar respuestas durante estos momentos de incertidumbre. BioReference Laboratories is accepting specimens for two types of COVID-19 testing, diagnostic molecular testing and serology antibody testing, from healthcare providers, clinics and health and hospital systems throughout the United States, to promote earlier diagnosis of the coronavirus, assess a patient’s immune response to the virus and aid in limiting spread of infection.

BioReference is offering a real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) assay, indicating an active infection as well as a semi-quantitative immunoassay that measures SARS-CoV-2 specific IgG antibody levels in the blood, detecting the patient’s immune response after COVID-19 infection. Both tests have been made available pursuant to the U.S. Food and Drug Administration Emergency Use Authorization for diagnostic testing in CLIA certified high-complexity laboratories. Para obtener más información, visite https://www.bioreference.com/coronavirus

Create Health’s Future

In response to the COVID-19 pandemic, Dr. Cohen spoke with the HLTH team to provide timely facts and updates. Watch the full interview.

If you are a healthcare provider, click here to become a client so you can begin ordering diagnostic tests from BioReference today!

Powered by Translations.com GlobalLink OneLink Software